Records containing: HIV-1-infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-04Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-01-23A Phase III, Randomized, Open-Label, Non-Inferiority Study of Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma in Resource-Limited Settings
-
CLINICAL_TRIALS study record update · 2026-01-23Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
-
CLINICAL_TRIALS study record update · 2026-01-22Efficacy and Safety of Doravirine in the Rapid Initiation of Highly Active Antiretroviral Therapy (HAART) in HIV-1positive Patients Without Prior Treatment
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase 2a Study to Evaluate the Safety and Tolerability of a Regimen of Dual Anti-HIV Envelope Antibodies, VRC07-523LS and CAP256V2LS, in a Sequential Regimen With a TLR7 Agonist, Vesatolimod, in Early Antiretroviral-Treated HIV-1 Clade C-Infected Women
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-12A Phase 2/3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
-
CLINICAL_TRIALS study record update · 2026-01-07Phase III, Open-label, Randomized, Multicenter Trial EvaLuating the Non-inferiority of DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2026-01-07Cannabis Use, Cognition, and the Endocannabinoid System in HIV
-
CLINICAL_TRIALS study record update · 2025-12-30IGHID 12230 - Scaling up the Brief Alcohol Intervention to Prevent HIV Infection in Vietnam: a Cluster Randomized, Implementation Trial (EBAI)
-
CLINICAL_TRIALS study record update · 2025-12-22ANRS 12424: Determination of Adequate Tuberculosis Regimen in Adults and Adolescents Hospitalized With HIV-associated Severe Immune Suppression (CD4 ≤ 100 Cells/µL): the DATURA Trial.
-
CLINICAL_TRIALS study record update · 2025-12-17Acute Neural and Immune Effects of Alcohol in People Living With HIV Infection
-
CLINICAL_TRIALS study record update · 2025-12-16A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA (Prime) Followed by DV701B1.1-RNA (Boost) in Adult Participants Without HIV
-
CLINICAL_TRIALS study record update · 2025-12-09Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed
-
CLINICAL_TRIALS study record update · 2025-11-17Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment
-
CLINICAL_TRIALS study record update · 2025-11-13A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)
-
CLINICAL_TRIALS study record update · 2025-11-05Phase 3 Double-blind Multicenter Randomized Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Biktarvy® (Bictegravir/Emtricitabine/Tenofovir Alafenamide) in Virologically Suppressed People With HIV-1
-
CLINICAL_TRIALS study record update · 2025-10-30An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study
-
CLINICAL_TRIALS study record update · 2025-10-22A Phase 1b/2 Dose Escalation Study of the Safety, Pharmacokinetics, and Efficacy of the Combination of TMB-365 and TMB-380 in HIV-1 Infected Individuals Suppressed With Combination Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2025-10-21An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1; Substudy-04: GS-1219
-
CLINICAL_TRIALS study record update · 2025-10-21Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV
-
CLINICAL_TRIALS study record update · 2025-10-20Extracts of Plants Eclipta Prostrata, Dioscorea Cirrhosa, Phyllanthus Urinaria, Adenosma Glutinosum, Impatiens Balsamina and Ascorbic Acid Use for in Protecting and Increasing CD4+ T Lymphocytes; B Lymphocytes Level in HIV/AIDS Patients.
-
CLINICAL_TRIALS study record update · 2025-10-20A Phase 3 Study of the Safety of Trogarzo® Administered as an Undiluted "IV Push" Over a Reduced Interval or as an Intramuscular Injection in Clinically Stable HIV-1 Infected Trogarzo® Experienced Patients and Healthy HIV-uninfected Volunteers
-
CLINICAL_TRIALS study record update · 2025-10-15ImproviNg Coronary Vascular Health in Women With Risk Factors fOR Myocardial Infarction Type 2 (INFORM-2)
-
CLINICAL_TRIALS study record update · 2025-10-14An Operationally Seamless Phase 2/3 Randomized, Open-label, Multicenter, Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Stable Baseline Regimen in Virologically Suppressed People With HIV-1 on Stable Complex Treatment Regimens
-
CLINICAL_TRIALS study record update · 2025-09-30Pilot Single-Arm Clinical Trial to Evaluate the Efficacy, PK Interactions and Safety of Dolutegravir Plus 2 NRTIs in HIV-1-Infected Solid Organ Transplant Patients